Lilly’s 2009 Growth Rides On Prasugrel; Advisory Committee’s Review Is Feb. 3

Firm reports ’08 net loss from ImClone deal and Zyprexa settlement

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet